Identification of molecular predictors of response in a study of tipifarnib treatment in relapsed and refractory acute myelogenous leukemia.

Source:http://linkedlifedata.com/resource/pubmed/id/17404110

Clin. Cancer Res. 2007 Apr 1 13 7 2254-60

Download in:

View as

General Info

PMID
17404110